PH16308A - Topical formulations containing 9-(2-hydroxyethoxymethyl)guanine and salts and esters thereof - Google Patents

Topical formulations containing 9-(2-hydroxyethoxymethyl)guanine and salts and esters thereof

Info

Publication number
PH16308A
PH16308A PH25929A PH25929A PH16308A PH 16308 A PH16308 A PH 16308A PH 25929 A PH25929 A PH 25929A PH 25929 A PH25929 A PH 25929A PH 16308 A PH16308 A PH 16308A
Authority
PH
Philippines
Prior art keywords
hydroxyethoxymethyl
guanine
esters
salts
formulations containing
Prior art date
Application number
PH25929A
Other languages
English (en)
Inventor
Trevor Mervin Jones
Alan Robert White
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26276273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH16308(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of PH16308A publication Critical patent/PH16308A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH25929A 1980-07-18 1981-07-17 Topical formulations containing 9-(2-hydroxyethoxymethyl)guanine and salts and esters thereof PH16308A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8023645 1980-07-18
GB8033218A GB2080106B (en) 1980-07-18 1980-10-15 Acyclovin preparations

Publications (1)

Publication Number Publication Date
PH16308A true PH16308A (en) 1983-09-05

Family

ID=26276273

Family Applications (1)

Application Number Title Priority Date Filing Date
PH25929A PH16308A (en) 1980-07-18 1981-07-17 Topical formulations containing 9-(2-hydroxyethoxymethyl)guanine and salts and esters thereof

Country Status (30)

Country Link
EP (1) EP0044543B1 (it)
AR (1) AR225680A1 (it)
AT (1) AT381025B (it)
AU (1) AU547391B2 (it)
BG (1) BG60450B2 (it)
CA (1) CA1172169A (it)
CS (1) CS229674B2 (it)
CY (1) CY1309A (it)
DD (1) DD203464A5 (it)
DE (1) DE3163982D1 (it)
DK (1) DK149191C (it)
ES (1) ES8305363A1 (it)
FI (1) FI76255C (it)
GB (1) GB2080106B (it)
GR (1) GR75104B (it)
HK (1) HK95485A (it)
HU (1) HU185936B (it)
IE (1) IE51120B1 (it)
IL (1) IL63351A (it)
IT (1) IT1171399B (it)
MC (1) MC1408A1 (it)
MY (1) MY8600389A (it)
NO (1) NO155038C (it)
NZ (1) NZ197744A (it)
PH (1) PH16308A (it)
PL (1) PL135416B1 (it)
PT (1) PT73391B (it)
RO (1) RO82678A (it)
SG (1) SG72085G (it)
ZW (1) ZW17181A1 (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095813A3 (en) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
GB8602346D0 (en) * 1986-01-30 1986-03-05 Wellcome Found Antiviral combinations
GB8917959D0 (en) * 1989-08-05 1989-09-20 Beecham Group Plc Pharmaceutical formulation
US6469015B1 (en) 1990-01-26 2002-10-22 Novartis International Pharmaceutical Ltd Pharmaceutical formulation
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
DK0561465T3 (da) * 1992-03-20 1998-04-14 Unichema Chemie Bv Slipmiddelsammensætning
DK169121B1 (da) * 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
DE4416674C2 (de) * 1994-05-11 1997-01-30 Rentschler Arzneimittel Topische Zubereitung enthaltend Aciclovir
DE19517147C2 (de) * 1995-05-10 1999-07-01 Hexal Pharmaforschung Gmbh Aciclovir-Zubereitung
AU2036297A (en) * 1996-03-20 1997-10-10 Glaxo Group Limited Topical formulations of aciclovir
GB9611167D0 (en) * 1996-05-29 1996-07-31 Glaxo Group Ltd Medicaments
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
GB9718791D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Medicaments
ITMI981528A1 (it) * 1998-07-03 2000-01-03 Recordati Ind Chimica E Farma Formulazioni topiche di aciclovir
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
GB9828620D0 (en) * 1998-12-23 1999-02-17 Glaxo Group Ltd Medicaments
FR2837102B1 (fr) * 2002-03-18 2004-10-08 Palbian Snc Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
CA2562190C (en) * 2004-04-05 2012-08-21 Laboratorios Liomont, S.A. De C.V. Novel antiviral pharmaceutical composition
EP2005824A1 (de) † 2007-06-21 2008-12-24 Bayer CropScience AG Wirkstoffsuspensionen in Glycerin
WO2017029298A1 (en) 2015-08-17 2017-02-23 Sanovel Ilac Sanayi Ve Ticaret A.S. A topical antiviral composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation
ZA738657B (en) * 1973-01-05 1974-10-30 Hoffmann La Roche Emulsions
GB1478009A (en) * 1973-04-02 1977-06-29 Glaxo Lab Ltd Pharmaceutical compositions
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
GB1543907A (en) * 1975-02-19 1979-04-11 Dermal Labor Ltd Steroid compositions
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4049802A (en) * 1975-03-19 1977-09-20 Research Corporation Zinc sulfadiazine and its use in the treatment of burns
GB1554720A (en) * 1975-07-10 1979-10-24 Nyegaard & Co As Pyridthione derivatives
US4144332A (en) * 1976-01-05 1979-03-13 The Regents Of The University Of Michigan Process for alleviating proliferative skin diseases
DE2847975A1 (de) * 1978-11-04 1980-05-14 Merck Patent Gmbh Verfahren zur bindung von freiem formaldehyd in pharmazeutischen und kosmetischen zubereitungen

Also Published As

Publication number Publication date
FI812257L (fi) 1982-01-19
AT381025B (de) 1986-08-11
CY1309A (en) 1985-12-06
PL232259A1 (en) 1983-07-04
ZW17181A1 (en) 1983-02-23
MY8600389A (en) 1986-12-31
GB2080106B (en) 1984-03-07
PT73391A (en) 1981-08-01
IT8148925A0 (it) 1981-07-17
GB2080106A (en) 1982-02-03
IL63351A (en) 1983-10-31
NZ197744A (en) 1983-05-10
BG60450B2 (bg) 1995-04-28
HU185936B (en) 1985-04-28
PT73391B (en) 1983-06-15
CS229674B2 (en) 1984-06-18
DK149191B (da) 1986-03-10
ES504046A0 (es) 1983-04-01
DD203464A5 (de) 1983-10-26
CA1172169A (en) 1984-08-07
NO155038B (no) 1986-10-27
SG72085G (en) 1986-05-02
DK321681A (da) 1982-01-19
NO155038C (no) 1987-02-04
ATA318081A (de) 1986-01-15
RO82678A (ro) 1984-05-23
IE51120B1 (en) 1986-10-01
MC1408A1 (fr) 1982-07-16
AU547391B2 (en) 1985-10-17
EP0044543B1 (en) 1984-06-06
HK95485A (en) 1985-12-06
FI76255C (fi) 1990-03-14
GR75104B (it) 1984-07-13
EP0044543A1 (en) 1982-01-27
IE811617L (en) 1982-01-18
IT1171399B (it) 1987-06-10
FI76255B (fi) 1988-06-30
DK149191C (da) 1986-09-08
AU7307381A (en) 1982-01-21
IL63351A0 (en) 1981-10-30
ES8305363A1 (es) 1983-04-01
DE3163982D1 (en) 1984-07-12
AR225680A1 (es) 1982-04-15
NO812464L (no) 1982-01-19
PL135416B1 (en) 1985-10-31

Similar Documents

Publication Publication Date Title
PH16308A (en) Topical formulations containing 9-(2-hydroxyethoxymethyl)guanine and salts and esters thereof
ZA786933B (en) Actinic radiation-curable formulations
HK82292A (en) Guanine compounds and their use for the preparation of antiviral agents
PH17975A (en) 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent and their pharmaceutical composition
IL70164A0 (en) Compositions containing 8-substituted guanine derivatives and methods of using same
HK126093A (en) Antiviral guanine derivatives
AU1527983A (en) Topical pharmaceutical compositions containing 9- (2-hydroxyethoxymethyl) guanine
GB2083470B (en) Theophylline and theobromine derivatives
NZ214534A (en) Sustained release formulation containing theophylline
GB2097785B (en) Novel purine derivatives
IE802177L (en) Imidazol-5-ylacetic acid derivatives
GB2092575B (en) 7-acylaminocephalosporanic acid derivatives
GB2022411A (en) Para-aminobencoic acid derivatives for use in therapy
IL68535A0 (en) Long-acting pharmaceutical compositions containing theophylline and cinnamic acid derivative and certain such novel derivatives
KE3561A (en) Topical formulations of 9-(2-hydroxyethoxymethyl)guanine
GB2048667B (en) Periodontal preparations containing folic acid
GB2088366B (en) Adenine derivatives
ZA833947B (en) Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl)guanine
GB2080796B (en) 2-hydroxy-5-phenylazobenzoic acid derivatives
GB2040297B (en) Actinic radiation-curable formulations
PH20807A (en) 2-amino-9-(2-hydroxyethoxymethyl)-9h-purine and salts thereof,their pharmaceutical formulations and their use
GB2048668B (en) Periodontal preparations containing folic acid
IE810338L (en) Calcitroic acid derivatives
GR871303B (en) 9-(2-hydroxy- ethoxy-methyl) guanine or acyclovir
IE831473L (en) Novel purine derivatives

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 13